newsfilter
← Latest News
GlobeNewswire·

Impact BioMedical's Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization's ISA Division

ROCHESTER, N.Y., March 03, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE:DSS), along with its scientific research partner Global Research and Discovery Group Sciences, (GRDG) announced it had received a